Emerging Infections Program

OMB Control No: 0920-0978	ICR Reference No: 202007-0920-014
Status: Historical Active	Previous ICR Reference No: 202006-0920-015
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-0978-20QT
Title: Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 07/31/2020
Retrieve Notice of Action (NOA)	Date Received in OIRA: 07/29/2020
Terms of Clearance: Previous terms continue: OMB is approving this information collection request for a period of three years during which time CDC will request approval to extend or revise the collection if the agency seeks to continue the information collection activity beyond the period approved under this action. Similarly, any changes to EIP as a result of ETEC pilot will be submitted for review and approval prior to fielding the data collection. Finally, approval is consistent with the understanding that CDC will continue to add language to its website and reports that clearly caveats the interpretation of longitudinal trends due to changes in the number and characteristics of participating hospitals

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	04/30/2022	04/30/2022	04/30/2022
Responses	99,955	0	138,735
Time Burden (Hours)	39,673	0	40,816
Cost Burden (Dollars)	0	0	0

---

Abstract: The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. This is a request for a non-substantive change. Requested changes represent minor modifications to already-approved instruments to include a limited number of data elements pertaining to COVID-19.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 57488	11/15/2018
30-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 5685	02/22/2019
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 32

IC Title Form No. Form Name COVID-19 - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB) 0920-0978 COVID-19 - Carbapenem Resistant Enterobacteriaceae (CRE)/ Carbapenem Resistant A. baumannii (CRAB) MUGSI-HAIC COVID-19 - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) 0920-0978 COVID-19 42020 Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae MuGSI-HAIC COVID-19 - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form 0920-0978 COVID-19 Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report – 2020 COVID-19 - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form 0920-0978 COVID -19 Invasive Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report – 2020 COVID-19 - CDI Case Report and Treatment Form 0920-0978 COVID-19 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE Flu Surv NET Laboratory Survey 0920-0978 FluSurv-NET Laboratory Survey 2019-2020 Season HAIC CDI LTCF Survey 0920-0978 Emerging Infections Progrom C. difficile Surveillance Nuring Home Telephone Call Survey Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (English) 0920-0978, 0920-0978 FluSurv NET Vaccination Phone Script ,   FluSurv NET Consent From English HAIC Invasive Staphylococcus aureus Annual Laboratory Survey 0920-0978 HAIC Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplificaiton Testing (NAAT) HAIC Invasive Staphylococcus aureus Annual Surveillance Officers Survey 0920-0978 2019 HAIC Invasive Staphylococcus aureus Supplemental Surveiallance Officer Survey ABCs Neonatal Infection Expanded Tracking Form 0920-0978 ABC Neonatal Infection Expanded Tracking Form Influenza Hospitalization Surveilance Network Case Report Form 0920-0978 2019-2020 FluSurv-NET Influenza Hospitalization Surveillance Project Case Report Form FoodNet Hemolytic Uremic Syndrome (HUS) 0920-0978 FoodNet HUS CRF FoodNet Campylobacter 0920-0978 FoodNet Active Surveillance Variable List FoodNet Cyclospora 0920-0978 FoodNet Active Surveillance Variable List FoodNet Listeria monocytogenes 0920-0978 FoodNet Active Surveillance Variable List FoodNet Salmonella 0920-0978 FoodNet Active Surveillance Variable List FoodNet Shigella 0920-0978 FoodNet Active Surveillance Variable List FoodNet Vibrio 0920-0978 FoodNet Active Surveillance Variable List FoodNet Yersinia 0920-0978 Foodborne and DIarrheal Diseases Message Mapping Guide (FDD MMG - FoodNet only portion) HAIC Multi-Site Gram-Negative Bacilli Case Report Form (MuGSI-CRE/CRAB) 0920-0978 2020 Carbapenem Resistant Enterobacteriaceae (CRE) Carbapenem Resistant A. baumannii (CRAB) Multi-site Gram-Negative Bacilli Case Report Form (MuGSI-CRE/CRAB) ABCs Severe GAS Infection Supplemental Form 0920-0978 ABC Severe GAS Infection Supplemental Form HAIC Multi-Site Gram-Negative Surveillance Initiative - Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae (MuGSI-ESBL) 0920-0978 2020 Extended-Spectrum Beta-Lactamase (ESBL)- Producting Enterobacteriaceae MuGSI (HAIC) HAIC Invasive Methicillin-Sensitive Staphylococcus aureus (MSSA) 0920-0978 Invasive Methicillin-Sensitive Staphylococcus aureau (HAIC) Case Report 2020 HAIC Candidemia Case Report Form 0920-0978 Candidemia 2020 Case Report Form HAIC Candidemia Periodic Laboratory Survey 0920-0978 2020 Laboratory Testing Practices for Candidemia Questionnaire Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults) 0920-0978 FluSurv Net Provider Vaccination History Fax Form Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (Spanish) 0920-0978, 0920-0978 FluSurv NET Vaccination Phone Script ,   FluSurv NET Consent Form Spanish FoodNet Shiga toxin producing E. coli 0920-0978 FoodNet Active Surveillance Variable List 2019-2020 ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form 0920-0978 ABC H. Influenzae Neonatal Sepsis Expanded Surveillance Form HAIC CDI Case Report Form 0920-0978 Clostridioides Difficile Infection (CDI Surveillance Emerging Infections Program Case Report ABCs Case Report Form 0920-0978 2020 ABC Surveillance Case Report HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA) 0920-0978 Invasive Methicillin-Resistant Staphylococcus aureus (MRSA) HAIC Case Report ABCs Invasive Pneumococcal Disease in Children 0920-0978 ABC Invasive Pneumococcal Disease in Children (age>2 months to <5 years HAIC CDI Annual Laboratory Survey 0920-0978 Annual Survey of Laboratory Testing Practices for C. difficile Infection HAIC CDI Annual Surveillance Officers Survey 0920-0978 Surveillance Officer's Survey Foodnet Clinical Laboratory Practices and Testing Volume 0920-0978 Foodnet Lab Practices Volume

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	99,955	138,735	0	0	-38,780	0
Annual Time Burden (Hours)	39,673	40,816	0	2,089	-3,232	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Addition of COVID-19 related questions to 0920-0978 EIP Forms results in increased burden hours for some instruments but an overall decrease due to entry error on last submission.

---

Annual Cost to Federal Government: $31,091,990

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Kevin Joyce 404 639-1944 [email protected]

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 07/29/2020

---